Consun Pharmaceutical Group (HKSE:01681) 3-Year FCF Growth Rate : 9.50% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group 3-Year FCF Growth Rate?

Consun Pharmaceutical Group's Free Cash Flow per Share for the six months ended in Dec. 2024 was HK$0.84.

During the past 12 months, Consun Pharmaceutical Group's average Free Cash Flow per Share Growth Rate was 19.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 9.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 24.60% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 19.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Consun Pharmaceutical Group was 68.30% per year. The lowest was -16.10% per year. And the median was 15.50% per year.

Competitive Comparison of Consun Pharmaceutical Group's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Consun Pharmaceutical Group's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's 3-Year FCF Growth Rate falls into.

Save Embed

;

Save Embed

;

Consun Pharmaceutical Group 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Consun Pharmaceutical Group (HKSE:01681) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Consun Pharmaceutical Group 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » 3-Year FCF Growth Rate

Traded in Other Exchanges

CPHGF:USA C1P:Germany

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Executives

Fmr Llc	2201 Interest of corporation controlled by you
Central Success Developments Limited	2101 Beneficial owner
Aali Resources Limited	2201 Interest of corporation controlled by you
Bos Trustee Limited	2301 Trustee
Assicurazioni Generali Spa	2201 Interest of corporation controlled by you
Gl China Long Equity Opportunities Fund Lp	2201 Interest of corporation controlled by you
Li Zhenfu	2201 Interest of corporation controlled by you
An Meng	2101 Beneficial owner
Zhang Lihua	2202 Interest of your spouse
Double Grace International Limited	2101 Beneficial owner
Li Qian	2101 Beneficial owner
An Yubao	2101 Beneficial owner
Bos Trustee Limited As Trustee	2201 Interest of corporation controlled by you

Consun Pharmaceutical Group Headlines

No Headlines